Opens in a new tab

DexCom v Abbott Laboratories (CFI, 21 November 2024)

Date21 November 2024
CourtCFI
DivisionDüsseldorf (DE) Local Division
Type of actionGeneric Order
Registry referenceORD_59318/2024
PartiesDexCom, Inc. v. Abbott Logistics B.V., Abbott Laboratories GmbH, Abbott Laboratories, Abbott Oy, Abbott Scandinavia Aktiebolag, Abbott (S.A./N…

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 21 November 2024 (UPC_CFI_499/2023, ACT_596853/2023, CC_33181/2024, ORD_59318/2024), the Düsseldorf Local Division (Judges Thomas, rapporteur, Thom and Rinkinen), hearing DexCom’s action for infringement of EP 4 026 488 against Abbott Laboratories and twelve other Abbott companies, met by a counterclaim for revocation, decided at this stage, with the parties’ consent, to hear both the infringement action and the counterclaim. The judge-rapporteur is to ask the President of the Court of First Instance to allocate a technically qualified judge. The interest of the order lies in its timing: the Art. 33(3) UPCA decision is taken before the written procedure closes, for reasons of court organisation.

Question

May the panel decide on the options under Art. 33(3) UPCA, where a counterclaim for revocation has been filed, before the end of the written procedure?

Decision

Rule 37.1 makes that choice a matter for the panel, and Rule 37.2 allows it to be taken by order before the end of the written procedure, after hearing the parties. The panel opted to hear both claims under Art. 33(3)(a) for reasons of efficiency: the same judges will decide validity and infringement on a uniform interpretation of the patent. The early decision is justified by the state of the Court, still under construction, with some members sitting part-time or case by case: allocating the technically qualified judge early lets that judge take part in case management and avoids scheduling delays. The decision also sets the framework of the proceedings for the parties and the Court.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 33(3)(a)
Rules of Procedure
Rules 37.1 and 37.2
Case law cited
No UPC decision is cited.

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Generic Order
Outcome (Dhenne Avocats summary)
La division locale de Düsseldorf décide, avant la fin de la procédure écrite et avec l'accord des parties, de juger ensemble la contrefaçon et la demande reconventionnelle en nullité, et fait demander l'affectation d'un juge techniquement qualifié.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 4 026 488Mentioned in the analysis (role not qualified)
Also mentioned in 2 other decision(s): DexCom v Abbott Laboratories (CFI, 7 January 2025) · DexCom v Abbott Laboratories (CFI, 20 November 2024)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.